Figures published in a new report released today (June 21, 2017; see hyperlink below) for the Scottish salmon farming industry show a dramatic decrease in the spend on medicinal treatments used to protect the salmon from attacks by sea lice.
According to the Scottish Salmon Producers’ Organisation (SSPO) in its Fish Health Management Annual Report, over the past 2 years, industry spend on medicinal treatments has dropped from 71% of total fish health management costs to 28%.
The change of strategy has also shown optimistic results with the SSPO reporting that by the end of last year (2016), sea lice management undertaken in line with the industry’s Code of Good Practice was the best it had been for some years.
Scott Landsburgh, chief executive of SSPO, said:
“Managing sea lice on the farms has become more challenging in the past few years with higher water temperatures and an increase in the incidences of algal blooms and jelly fish. However, the investment in cleaner fish like wrasse and lumpfish as well as the new machinery to remove lice is proving successful and looks encouraging for the future. We will always need responsible access to medicines as part of a multi-faceted strategy, but this has been a significant turn-around for the salmon farmers.”
Cleaner fish like wrasse and lumpfish are now used on farms and in entire regions, which have produced impressive results in sea lice management. All the lumpfish used are farmed and the production of farmed wrasse is increasing.
Significant investment of around £14M has been made in the development of cleaner fish including an increase in the number of facilities producing farmed wrasse, although more are still needed.
“Wrasse and lumpfish are becoming a key part of fish farming and the potential to farm wrasse for the salmon farming sector is an exciting opportunity for further investment and jobs in Scotland.
“Of course, as we are dealing with livestock, there will always be a requirement for the use of medicinal treatments and it is important that we ensure long term responsible access to medicines which give the fish some protection. Maintaining a range of options like the in-feed SLICE treatment is a key part of the industry’s fish health management strategy.”
Last year also saw £21M invested in the use of mechanical methods to remove lice. These devices use water and temperature to remove the lice from the salmon and can be used whenever required. Although they are still early in their development, results are encouraging and companies are training dedicated teams of workers to establish best practice.
Salmon farming companies who form the membership of the SSPO have been investing in research, in establishing the production of farmed wrasse at Machrihanish and Ardtoe and in training and further recruitment of biologists, health managers and vets who ensure high standards of fish health and welfare.
Looking ahead, at least two new freshwater hatcheries will be built to produce larger salmon smolts with high health status for transferring to marine water farms. This will reduce growing time at sea and also reduce exposure to sea lice. The hatcheries are due to be completed by 2019. The industry is also working with Marine Scotland, SEPA and the Scottish Aquaculture Innovation Centre to develop a 10 year fish health management strategy to complement industry growth and to ensure its long-term sustainable production.
Photographs of Scott Landsburgh as well as shots of wrasse are attached along with a video in which wrasse are seen swimming with salmon and the process is explained by John Rea, production director of Scottish Sea Farms.
- Photos: https://www.dropbox.com/sh/eteusm5cf2lbmsp/AACiywr4Lfvkr7AdwASHaoqZa?dl=0
- Film (1.06 – 1.22) https://www.youtube.com/watch?v=ATDa9i7rbAs
- Fish Health Annual Report
Source: SSPO PR (dated 16.06.2017, but released 21.06.2017)